El primer episodio estará dedicado a uno de los grandes campos de la innovación a nivel mundial, uno de los que más dudas y controversias genera y que, en tiempos de pandemia y de vacunas, está de plena actualidad. Hablaremos de las patentes biotecnológicas con la participación de Nicolás Vincent Ruiz, Global Intellectual Property Head de ESTEVE, junto a Patricia Ramos, directora Área Patentes PONS IP y Ana Herrera Arroyo, responsable de Biotecnología del Área Patentes PONS IP a la que también hemos entrevistado. Para la firma invitada, contaremos con la participación de José Antonio Gil Celedonio, director de la Oficina Española de Patentes y Marcas (OEPM).
IP newsthat
may interest you
PONS IP, a global consulting firm specialising in intellectual property, new technologies and innovation, has been recognised by the Financial Times as a leading firm in Spain in its prestigious “Europe’s Leading Patent Law Firms” 2026 ranking, consolidating its position...
Plant innovation does not fail due to a lack of potential, but rather because of incomplete or belated protection strategies. Integrating industrial property rights from the outset enables R&D to be transformed into a competitive advantage and a genuine source...
By Ana Herrera, Director of Patents, Technological Development and Innovation and Guillermo Criado, Director of International Business Development Last December, the Japan Patent Office registered nearly 82,000 applications in a single month, well above the usual 20,000 or 30,000. In...
NEWSLETTER
All the IP News
in your e-mail
Find out all the latest information on IP to boost the development of your organisation.
Subscribe to our bimonthly newsletter
International Awards
and Recognitions


